New Fusion Molecule Seen as Avenue for Pursuing Slice of $127 Billion Market

Kraig Biocraft Laboratories, Inc. (OTCBB:KBLB) announced today that the Company, working in cooperation with leading university laboratories, is synthesizing DNA sequences for artificial spider silk based polymers. The artificial DNA which the Company is developing relates to the discovery of a chimera molecule, the subject of a 2008 provisional patent filing, which incorporates high strength spider silk proteins.

"Our artificial DNA sequences are designed for use in the development and production of a new class of high performance fibers," said Kraig's CEO Kim Thompson. "We are developing these fibers, spider silk analogs, specifically to capture a share of the growing technical fibers market. This is the primary market for high strength fibers. The market for technical fibers is booming. Within two years it is projected to grow to $127 billion. We believe that these revolutionary materials will have tremendous potential in the technical textiles marketplace for high strength polymers."

"What is exciting for the industry is the tremendous potential of these high strength fibers to satisfy the multi-billion dollar demand for new materials with tremendous strength to weight ratios," said Thompson. "The artificial DNA sequences are one of the keys to satisfying that demand."

Kraig Biocraft Laboratories is a technology company focused on the development of commercially significant high-performance polymers and technical fiber. Based on proprietary genetic engineering technology, Kraig is working to develop and produce polymers and protein-based materials including Spider Silk.

For more information on Kraig Biocraft Laboratories please visit the Company's web site: http://www.KraigLabs.com

An audio interview discussing corporate developments is also available on the website.